Trademark Overview
On Tuesday, September 17, 2024, a trademark application was filed for HAPILTO with the United States Patent and Trademark Office. The USPTO has given the HAPILTO trademark a serial number of 98754628. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 31, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The HAPILTO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders